Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Melissa Y. Yeung"'
Publikováno v:
Case Reports in Transplantation, Vol 2019 (2019)
Hyperoxaluria is an important and underrecognized cause for allograft dysfunction and loss after transplantation. It is potentially treatable if recognized in a timely fashion. Research is ongoing to expand the array of therapeutic options available
Externí odkaz:
https://doaj.org/article/7c1b686c70be447ba8ac2df5130805b3
Autor:
Melissa Y. Yeung
Publikováno v:
Brazilian Journal of Nephrology
Externí odkaz:
https://doaj.org/article/95f4f6d1c82e46f7aa35f76a21572612
Autor:
Abigail Joseph, Cody J. Murray, Natasha D. Novikov, Randall W. Velliquette, Sunitha Vege, Justin B.L. Halls, Helen H. Mah, Jamie L. Dellagatta, Edward Comeau, Maria Aguad, Richard M. Kaufman, Martin L. Olsson, Indira Guleria, Sean R. Stowell, Edgar L. Milford, Annika K. Hult, Melissa Y. Yeung, Connie M. Westhoff, Cathi L. Murphey, William J. Lane
Publikováno v:
American Journal of Transplantation. 23:512-519
Autor:
Melissa Y. Yeung, Naoka Murakami, Maria L. Kafetzi, Daimon P. Simmons, Isabelle Wood, Peter Macaskill, Matthew Towle, Jaime Della Gatta, Jonathan Stevens, Edward Comeau, Jane Baronas, Nabil Mohsin, Mike Chen, Jar-How Lee, William J. Lane, Edgar L. Milford, Indira Guleria
Publikováno v:
American Journal of Transplantation.
Publikováno v:
Seminars in nephrology.
Transplantation is a life-saving medical intervention that unfortunately is constrained by scarcity of available organs. An ideal system for allocating organs should seek to achieve the greatest good for the greatest number of people. It also must be
Autor:
Melissa Y. Yeung
Publikováno v:
Seminars in nephrology. 42(1)
Human Leukocyte Antigen (HLA) diversity is the key driver of alloimmune responses. Ideally, patients would receive an allograft that is fully matched at the allelic level. However, the extensive polymorphism in the HLA loci renders this impractical.
Autor:
Amr Mansouri, Siawosh K. Eskandari, Harvey Cantor, John Choi, Jamil Azzi, Melissa Y. Yeung, Eman Alhussain, Saif A. Muhsin, Songjie Cai, Hye-Jung Kim, Hazim Allos, Jean Pierre Assaker, Marc A. Seelen, Ina Sulkaj, Juliano B. Alhaddad
Publikováno v:
Proc Natl Acad Sci U S A
Proceedings of the National Academy of Sciences of the United States of America, 117(11), 6042-6046. NATL ACAD SCIENCES
Proceedings of the National Academy of Sciences of the United States of America, 117(11), 6042-6046. NATL ACAD SCIENCES
Induction of longstanding immunologic tolerance is essential for survival of transplanted organs and tissues. Despite recent advances in immunosuppression protocols, allograft damage inflicted by antibody specific for donor organs continues to repres
Autor:
Shang-Chuen Wu, Nourine A. Kamili, Marcelo Dias-Baruffi, Cassandra D. Josephson, Matthew F. Rathgeber, Melissa Y. Yeung, William J. Lane, Jianmei Wang, Hau-Ming Jan, Seth Rakoff-Nahoum, Richard D. Cummings, Sean R. Stowell, Connie M. Arthur
Publikováno v:
iScience. 25:104482
Adaptive immunity can target a nearly infinite range of antigens, yet it is tempered by tolerogenic mechanisms that limit autoimmunity. Such immunological tolerance, however, creates a gap in adaptive immunity against microbes decorated with self-lik
Autor:
Melissa Y. Yeung
Publikováno v:
Brazilian Journal of Nephrology, Issue: ahead, Published: 01 JUN 2020
Jornal Brasileiro de Nefrologia
Brazilian Journal of Nephrology v.42 n.2 2020
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Brazilian Journal of Nephrology
Jornal Brasileiro de Nefrologia
Brazilian Journal of Nephrology v.42 n.2 2020
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Brazilian Journal of Nephrology
Donor-specific antibodies (DSAs) directed against HLA antigens are central to the development of antibody-mediated rejection and chronic allograft vasculopathy, the leading causes of long-term transplant failure. DSAs can be preexisting (preformed) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb8b74b08cc3c1aa5da297168f26afc
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020005017203&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020005017203&lng=en&tlng=en
Publikováno v:
Expert Opinion on Biological Therapy. 17:339-352
For over thirty years, antibody (mAb)-based therapies have been a standard component of transplant immunosuppression, and yet much remains to be learned in order for us to truly harness their therapeutic capabilities. Current mAbs used in transplant